Associated Papers
How We Treat Hemolytic Anemia Due to Pyruvate Kinase Deficiency.
Tama-Shekan S et al.
Hematology Reports, 2024
Investigating rare pathogenic/likely pathogenic exonic variation in bipolar disorder.
Jia X et al.
Molecular Psychiatry, 2021
33483695 (PubMed )
Supplement: 41380_2020_1006_MOESM2_ESM.xlsx › S2
Prevalence of pyruvate kinase deficiency: A systematic literature review.
Secrest MH et al.
European Journal of Haematology, 2020
Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency.
Bianchi P et al.
American Journal of Hematology, 2020
AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency.
Kung C et al.
Blood, 2017
Six previously undescribed pyruvate kinase mutations causing enzyme deficiency.
Demina A et al.
Blood, 1998
Novel mutations and structural implications in R-type pyruvate kinase-deficient patients from Southern Italy.
Pastore L et al.
Human Mutation, 1998
Pyruvate kinase deficient hemolytic anemia in the Northern Irish population.
Percy MJ et al.
Blood Cells, Molecules & Diseases, 0
Select a paper to view details